Vial Adapter for Device

DEVICE2 trials

Sponsors

Takeda, Shire

Conditions

Short Bowel Syndrome

Phase 3

An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004

CompletedNCT03596164

TakedaShort Bowel Syndrome

Start: 2018-07-09End: 2022-01-13Updated: 2023-03-15

Study of Teduglutide in Japanese Participants With Short Bowel Syndrome

CompletedNCT03663582

ShireShort Bowel Syndrome

Start: 2018-07-06End: 2019-08-06Updated: 2020-08-04